Evidence map›Paper›PMID 30100945›Full record

ArticleNuclear medicine and molecular imaging2018

Bone and Calcified Soft Tissue Metastases of Medullary Thyroid Carcinoma Better Characterized on

Paulo Schiavom Duarte, Luciana Audi de Castroneves, Heitor Naoki Sado, Marcelo Tatit Sapienza, Ana Amélia Fialho de Oliveira Hoff, Carlos Alberto Buchpiguel

Open access · bronzeAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Nuclear medicine and molecular imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Correlation ofArchives of endocrinology and metabolism · 2024
    Article
  3. Comparison ofNuclear medicine and molecular imaging · 2020
    Article
  4. Letter to the Editor:European journal of nuclear medicine and molecular imaging · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Paulo Schiavom Duarte1Division of Nuclear Medicine, São Paulo Cancer Institute (ICESP), Av. Dr. Arnaldo, 251, 4° SS, Cerqueira César, São Paulo, SP 01246-000 Brazil.ORCID 0000-0003-4517-4410
Luciana Audi de Castroneves2Division of Endocrinology, São Paulo Cancer Institute (ICESP), São Paulo, Brazil.
Heitor Naoki Sado1Division of Nuclear Medicine, São Paulo Cancer Institute (ICESP), Av. Dr. Arnaldo, 251, 4° SS, Cerqueira César, São Paulo, SP 01246-000 Brazil.
Marcelo Tatit Sapienza1Division of Nuclear Medicine, São Paulo Cancer Institute (ICESP), Av. Dr. Arnaldo, 251, 4° SS, Cerqueira César, São Paulo, SP 01246-000 Brazil.
Ana Amélia Fialho de Oliveira Hoff2Division of Endocrinology, São Paulo Cancer Institute (ICESP), São Paulo, Brazil.
Carlos Alberto Buchpiguel1Division of Nuclear Medicine, São Paulo Cancer Institute (ICESP), Av. Dr. Arnaldo, 251, 4° SS, Cerqueira César, São Paulo, SP 01246-000 Brazil.
Instituto do Câncer do Estado de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herein, we report a case of a 19-year-old man with multiple endocrine neoplasia type 2B (MEN2B) and medullary thyroid carcinoma (MTC) diagnosed when he was 12 years of age. The patient had previously undergone total thyroidectomy, cervical radiotherapy, and chemotherapy. He progressed with known bone, pulmonary, and lymph node metastases and was scanned with

Indexed as

18F18F-NaF68GaGallium-68Medullary thyroid carcinomaPET/CT

Identifiers

PMID30100945
PMCPMC6066486
OpenAlexW2806053715

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.